title: MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.
abstract: Focused ultrasound offers a method to disrupt the blood-brain barrier (BBB) noninvasively and reversibly at targeted locations. The purpose of this study was to test the safety of this method by searching for ischemia and apoptosis in areas with BBB disruption induced by pulsed ultrasound in the presence of preformed gas bubbles and by looking for delayed effects up to one month after sonication. Pulsed ultrasound exposures (sonications) were performed in the brains of 24 rabbits under monitoring by magnetic resonance imaging (MRI) (ultrasound: frequency = 1.63 MHz, burst length = 100 ms, PRF = 1 Hz, duration = 20 s, pressure amplitude 0.7 to 1.0 MPa). Before sonication, an ultrasound contrast agent (Optison, GE Healthcare, Milwaukee, WI, USA) was injected IV. BBB disruption was confirmed with contrast-enhanced MR images. Whole brain histologic examination was performed using haematoxylin and eosin staining for general histology, vanadium acid fuchsin-toluidine blue staining for ischemic neurons and TUNEL staining for apoptosis. The main effects observed were tiny regions of extravasated red blood cells scattered around the sonicated locations, indicating affected capillaries. Despite these vasculature effects, only a few cells in some of the sonicated areas showed evidence for apoptosis or ischemia. No ischemic or apoptotic regions were detected that would indicate a compromised blood supply was induced by the sonications. No delayed effects were observed either by MRI or histology up to 4 wk after sonication. Ultrasound-induced BBB disruption is possible without inducing substantial vascular damage that would result in ischemic or apoptotic death to neurons. These findings indicate that this method is safe for targeted drug delivery, at least when compared with the currently available invasive methods.
authors.affiliation: Department of Radiology, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. njm@bwh.harvard.edu
authors.forename: Nathan
authors.initials: N
authors.lastname: McDannold
authors.forename: Natalia
authors.initials: N
authors.lastname: Vykhodtseva
authors.forename: Scott
authors.initials: S
authors.lastname: Raymond
authors.forename: Ferenc A
authors.initials: FA
authors.lastname: Jolesz
authors.forename: Kullervo
authors.initials: K
authors.lastname: Hynynen
mesh_terms: D000418:Albumins / Q000008:administration & dosage; D000818:Animals; D017209:Apoptosis; D001812:Blood-Brain Barrier / Q000000981:diagnostic imaging* / Q000473:pathology; D001921:Brain / Q000473:pathology; D002545:Brain Ischemia / Q000473:pathology; D002452:Cell Count; D004453:Echoencephalography / Q000295:instrumentation / Q000379:methods*; D005466:Fluorocarbons / Q000008:administration & dosage; D020287:In Situ Nick-End Labeling; D008279:Magnetic Resonance Imaging; D008297:Male; D045423:Microbubbles; D023421:Models, Animal; D009474:Neurons / Q000473:pathology; D011817:Rabbits
chemical_list: D000418:Albumins; C099458:FS 069; D005466:Fluorocarbons